Moderna launch Omicron-specific UK vaccine study
pharmafile | February 16, 2022 | News story | Research and Development |
Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The jab, which is one of the world’s first to tackle the variant, will be trialled at various sites across the UK, in a partnership between Moderna and the National Institute for Health Research (NIHR).
The study will be led by a team based at the St George’s, University of London. Half of the volunteers participating in the study will receive the new jab, while the other half will be vaccinated with Moderna’s regular vaccine.
Immunity wanes several months after COVID-19 booster doses, meaning clinical trials are needed to determine whether people may need a fourth booster dose. The new trial will also seek to recruit people who have had just two doses of a vaccine and have not yet had a booster.
“The UK is a world leader when it comes to the research and development of vaccines and medicines, bolstered by our renowned life sciences industry,” Health Secretary Sajid Javid said. “It’s fantastic to see these capabilities being put to good use, with almost 3,000 people expected to take part in this important clinical trial. I want this country to be the best place in the world to launch clinical trials.”
“The UK and NIHR have been pioneering in their work to study vaccines and therapeutics throughout the global pandemic and have built up world-class clinical research capabilities,” Stephane Bancel, chief executive officer of Moderna, commented. “This is the first Moderna-sponsored Phase 3 study to be conducted outside of the US with our Omicron-specific booster candidate and we appreciate the collaboration with the NIHR.”
The news arrives as Moderna reportedly looks to base a research facility in the UK, after its pandemic-popularity has fuelled rapid expansion plans. Moderna previously had one facility on the outskirts of Boston.
“I urge anyone eligible to take part in this vital research and play their part in protecting the country for years to come as we learn to live with COVID-19,” Health Secretary Sajid Javid concluded.
Ana Ovey
